Tech Company Financing Transactions
Amphora Discovery Funding Round
Amphora Discovery, based in Research Triangle Park, raised $20 million in investment from Novartis BioVenture Fund, 3i Venture Capital and Arch Venture Partners.
Transaction Overview
Company Name
Announced On
12/8/2004
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series C
Investors
Proceeds Purpose
The funds raised in this round will allow Amphora to remain focused on advancing drug discovery programs for our partners as well as accelerating the preclinical development of our internal drug candidates.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
PO Box 12169
Research Triangle Park, NC 27709
USA
Research Triangle Park, NC 27709
USA
Phone
Website
Email Address
Overview
Amphora Discovery Corporation is a privately held next-generation drug discovery company with a highly industrialized approach to pathway-based drug discovery of therapeutics for human diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Janzen
Chief Financial Officer
Peter Heath
VP - Bus. Development
Julian Abery
VP - Operations
Carla Suto
Browse more venture capital transactions:
Prev: 12/7/2004: Kollective venture capital transaction
Next: 12/8/2004: IBSN venture capital transaction
Share this article
Where The Data Comes From
We report on tech company VC transactions. VC transactions reported here are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs